Joanna C. Dalland

Dr. Joanna C. Dalland is a Hematopathologist at Mayo Clinic in Rochester, Minnesota, specializing in myeloid and lymphoid neoplasms and amyloidosis. She is affiliated with the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine, where she contributes to clinical diagnostics, research, and medical education. As a board-certified specialist in both Anatomic & Clinical Pathology and Hematopathology, Dr. Dalland plays a critical role in diagnosing complex hematologic disorders and advancing the field through her research.

Dr. Dalland's educational background includes:

• 2019: Fellow in Hematopathology, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
• 2018: Chief Resident and Resident in Anatomic and Clinical Pathology, University of Kentucky
• 2014: Doctorate of Medicine, Albany Medical College
• 2012: Post Doctoral Fellowship in Anatomic and Clinical Pathology, Medical University of South Carolina
• 2008: BS in Physics on a Biological Tract, Siena College (Magna cum laude)

Dr. Dalland's research primarily focuses on amyloidosis, with particular expertise in identifying and characterizing various forms including AL amyloidosis, ATTR amyloidosis, and AApoAIV amyloidosis across different organ systems. Her work spans gastrointestinal, urinary tract, salivary gland, and splenic amyloidosis, utilizing advanced proteomic techniques for precise diagnosis. She also investigates myeloid and lymphoid neoplasms, with publications on myelodysplastic syndromes, plasma cell neoplasms, and genetic abnormalities in hematologic malignancies. Her research bridges diagnostic pathology with clinical implications, emphasizing how early detection can inform systemic disease management.

Dr. Dalland's publication record demonstrates a clear research trajectory centered on amyloidosis characterization across multiple organ systems. Her recent work increasingly employs proteomic identification techniques to precisely classify amyloid types, which has significant implications for targeted treatment approaches. She has made notable contributions to understanding rare presentations of amyloidosis and dual amyloid deposition. Additionally, her research spans hematologic malignancies, with focus on genetic abnormalities in myeloid neoplasms and lymphomas. This dual focus on amyloidosis and hematologic malignancies positions her work at the intersection of diagnostic pathology and precision medicine.

Dr. Dalland has received several notable honors:

• 2024: ISA Presidential Award from the International Society of Amyloidosis
• 2008: Magna cum laude graduate from Siena College

She maintains active professional memberships including the Society for Hematopathology (2019-present), American Society for Clinical Pathology (2015-present), College of American Pathologists (2015-present), and the United States and Canadian Academy of Pathology (2015-present).

While specific details about her advisees are not provided in the available information, Dr. Dalland's role as a Hematopathology Fellow at Mayo Clinic suggests she participates in training pathology residents and fellows. Her extensive publication record with multiple co-authors indicates active collaboration within Mayo Clinic's pathology department and with external researchers. Her research appears to be supported by Mayo Clinic's institutional resources, particularly for studies involving proteomic identification techniques and multi-institutional case series.

Dr. Dalland works within Mayo Clinic's Department of Laboratory Medicine and Pathology, specifically in the hematology and hematopathology division. Her research demonstrates close collaboration with the Amyloidosis Research Group at Mayo Clinic, particularly with colleagues like Dr. Surendra Dasari, Dr. Stephen H. Nasr, and Dr. Ellen D. McPhail. She also works with the Proteomics Laboratory at Mayo Clinic for amyloid typing, which represents a cutting-edge approach to diagnosing and classifying amyloidosis. Her work bridges diagnostic pathology with clinical hematology, contributing to Mayo Clinic's comprehensive amyloidosis program.